Skip to main content

Advertisement

Open Peer Review Reports for: Anti-angiogenesis therapy based on the bone marrow-derived stromal cells genetically engineered to express sFlt-1 in mouse tumor model

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
13 Oct 2007 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
3 Dec 2007 Reviewed Reviewer Report - Vincent Kindler
1 Jun 2008 Author responded Author comments - Hu Min
Resubmission - Version 3
1 Jun 2008 Submitted Manuscript version 3
23 Jun 2008 Reviewed Reviewer Report - Vincent Kindler
5 Aug 2008 Author responded Author comments - Hu Min
Resubmission - Version 4
5 Aug 2008 Submitted Manuscript version 4
25 Sep 2008 Author responded Author comments - Hu Min
Resubmission - Version 5
25 Sep 2008 Submitted Manuscript version 5
27 Sep 2008 Author responded Author comments - Hu Min
Resubmission - Version 6
27 Sep 2008 Submitted Manuscript version 6
Publishing
23 Oct 2008 Editorially accepted
23 Oct 2008 Article published 10.1186/1471-2407-8-306

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement